nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—Cytochrome P450 3A4 Inhibitors—Ticagrelor—coronary artery disease	0.441	1	CiPCiCtD
Atazanavir—SLCO1B3—Olmesartan—coronary artery disease	0.0391	0.0947	CbGbCtD
Atazanavir—SLCO1B3—Pitavastatin—coronary artery disease	0.0312	0.0757	CbGbCtD
Atazanavir—SLCO1B3—Telmisartan—coronary artery disease	0.0312	0.0757	CbGbCtD
Atazanavir—SLCO1B3—Valsartan—coronary artery disease	0.0304	0.0736	CbGbCtD
Atazanavir—SLCO1B3—Rosuvastatin—coronary artery disease	0.023	0.0558	CbGbCtD
Atazanavir—SLCO1B3—Pravastatin—coronary artery disease	0.021	0.0508	CbGbCtD
Atazanavir—SLCO1B3—Atorvastatin—coronary artery disease	0.0191	0.0462	CbGbCtD
Atazanavir—SLCO1B3—Losartan—coronary artery disease	0.0175	0.0423	CbGbCtD
Atazanavir—ABCC1—Rosuvastatin—coronary artery disease	0.0159	0.0386	CbGbCtD
Atazanavir—ABCC1—Atorvastatin—coronary artery disease	0.0132	0.032	CbGbCtD
Atazanavir—ABCB1—Ticagrelor—coronary artery disease	0.00965	0.0234	CbGbCtD
Atazanavir—CYP2C9—Fenofibrate—coronary artery disease	0.00886	0.0215	CbGbCtD
Atazanavir—CYP2C9—Gemfibrozil—coronary artery disease	0.00709	0.0172	CbGbCtD
Atazanavir—CYP2C9—Clopidogrel—coronary artery disease	0.00614	0.0149	CbGbCtD
Atazanavir—ABCB1—Perindopril—coronary artery disease	0.00596	0.0144	CbGbCtD
Atazanavir—ABCB1—Clopidogrel—coronary artery disease	0.00596	0.0144	CbGbCtD
Atazanavir—CYP3A4—Ticagrelor—coronary artery disease	0.00578	0.014	CbGbCtD
Atazanavir—CYP2C9—Pitavastatin—coronary artery disease	0.00537	0.013	CbGbCtD
Atazanavir—CYP2C9—Valsartan—coronary artery disease	0.00522	0.0127	CbGbCtD
Atazanavir—ABCB1—Pitavastatin—coronary artery disease	0.00521	0.0126	CbGbCtD
Atazanavir—ABCB1—Telmisartan—coronary artery disease	0.00521	0.0126	CbGbCtD
Atazanavir—CYP3A4—Fenofibrate—coronary artery disease	0.00515	0.0125	CbGbCtD
Atazanavir—ABCB1—Enalapril—coronary artery disease	0.00494	0.012	CbGbCtD
Atazanavir—ABCB1—Lisinopril—coronary artery disease	0.00494	0.012	CbGbCtD
Atazanavir—ABCB1—Timolol—coronary artery disease	0.0042	0.0102	CbGbCtD
Atazanavir—CYP3A4—Gemfibrozil—coronary artery disease	0.00412	0.00998	CbGbCtD
Atazanavir—CYP2C9—Rosuvastatin—coronary artery disease	0.00396	0.00959	CbGbCtD
Atazanavir—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00386	0.00935	CbGbCtD
Atazanavir—ABCB1—Ezetimibe—coronary artery disease	0.00384	0.00931	CbGbCtD
Atazanavir—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00374	0.00907	CbGbCtD
Atazanavir—ABCB1—Captopril—coronary artery disease	0.0037	0.00896	CbGbCtD
Atazanavir—CYP2C9—Simvastatin—coronary artery disease	0.00368	0.00892	CbGbCtD
Atazanavir—CYP2C9—Pravastatin—coronary artery disease	0.0036	0.00873	CbGbCtD
Atazanavir—CYP2C9—Lovastatin—coronary artery disease	0.0036	0.00873	CbGbCtD
Atazanavir—CYP3A4—Clopidogrel—coronary artery disease	0.00357	0.00865	CbGbCtD
Atazanavir—ABCB1—Simvastatin—coronary artery disease	0.00357	0.00865	CbGbCtD
Atazanavir—ABCB1—Pravastatin—coronary artery disease	0.0035	0.00847	CbGbCtD
Atazanavir—ABCB1—Lovastatin—coronary artery disease	0.0035	0.00847	CbGbCtD
Atazanavir—CYP3A4—Eplerenone—coronary artery disease	0.00332	0.00805	CbGbCtD
Atazanavir—CYP2C9—Atorvastatin—coronary artery disease	0.00328	0.00795	CbGbCtD
Atazanavir—ABCB1—Atorvastatin—coronary artery disease	0.00318	0.00771	CbGbCtD
Atazanavir—CYP2C9—Losartan—coronary artery disease	0.003	0.00727	CbGbCtD
Atazanavir—CYP3A4—Enalapril—coronary artery disease	0.00296	0.00717	CbGbCtD
Atazanavir—ABCB1—Losartan—coronary artery disease	0.00291	0.00705	CbGbCtD
Atazanavir—CYP3A4—Rosuvastatin—coronary artery disease	0.0023	0.00558	CbGbCtD
Atazanavir—CYP3A4—Ezetimibe—coronary artery disease	0.0023	0.00558	CbGbCtD
Atazanavir—CYP3A4—Simvastatin—coronary artery disease	0.00214	0.00518	CbGbCtD
Atazanavir—CYP3A4—Pravastatin—coronary artery disease	0.00209	0.00507	CbGbCtD
Atazanavir—CYP3A4—Lovastatin—coronary artery disease	0.00209	0.00507	CbGbCtD
Atazanavir—CYP3A4—Atorvastatin—coronary artery disease	0.00191	0.00462	CbGbCtD
Atazanavir—CYP3A4—Losartan—coronary artery disease	0.00174	0.00423	CbGbCtD
Atazanavir—CYP2C9—cardial valve—coronary artery disease	0.000585	0.643	CbGeAlD
Atazanavir—Lopinavir—CYP2C19—coronary artery disease	0.00031	0.353	CrCbGaD
Atazanavir—Ritonavir—CYP2C19—coronary artery disease	0.000261	0.297	CrCbGaD
Atazanavir—Saquinavir—CYP2C19—coronary artery disease	0.000198	0.225	CrCbGaD
Atazanavir—Saquinavir—ALB—coronary artery disease	0.00011	0.125	CrCbGaD
Atazanavir—ABCC1—myocardium—coronary artery disease	6.13e-05	0.0673	CbGeAlD
Atazanavir—ABCC1—heart—coronary artery disease	4.28e-05	0.047	CbGeAlD
Atazanavir—ABCC1—cardiac atrium—coronary artery disease	3.66e-05	0.0402	CbGeAlD
Atazanavir—CYP2C9—heart—coronary artery disease	3.23e-05	0.0355	CbGeAlD
Atazanavir—ABCC1—blood—coronary artery disease	3.19e-05	0.0351	CbGeAlD
Atazanavir—CYP2C9—cardiovascular system—coronary artery disease	3.05e-05	0.0335	CbGeAlD
Atazanavir—Anxiety—Timolol—coronary artery disease	2.8e-05	0.000226	CcSEcCtD
Atazanavir—Angioedema—Lisinopril—coronary artery disease	2.79e-05	0.000226	CcSEcCtD
Atazanavir—Pruritus—Olmesartan—coronary artery disease	2.79e-05	0.000226	CcSEcCtD
Atazanavir—Decreased appetite—Losartan—coronary artery disease	2.79e-05	0.000226	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	2.79e-05	0.000226	CcSEcCtD
Atazanavir—Abdominal pain—Captopril—coronary artery disease	2.79e-05	0.000226	CcSEcCtD
Atazanavir—Body temperature increased—Captopril—coronary artery disease	2.79e-05	0.000226	CcSEcCtD
Atazanavir—Dizziness—Simvastatin—coronary artery disease	2.78e-05	0.000225	CcSEcCtD
Atazanavir—Rash—Ezetimibe—coronary artery disease	2.78e-05	0.000225	CcSEcCtD
Atazanavir—Dermatitis—Ezetimibe—coronary artery disease	2.78e-05	0.000225	CcSEcCtD
Atazanavir—Confusional state—Ramipril—coronary artery disease	2.78e-05	0.000225	CcSEcCtD
Atazanavir—Discomfort—Timolol—coronary artery disease	2.77e-05	0.000225	CcSEcCtD
Atazanavir—Asthenia—Niacin—coronary artery disease	2.77e-05	0.000224	CcSEcCtD
Atazanavir—Fatigue—Losartan—coronary artery disease	2.77e-05	0.000224	CcSEcCtD
Atazanavir—Headache—Ezetimibe—coronary artery disease	2.76e-05	0.000224	CcSEcCtD
Atazanavir—Malaise—Lisinopril—coronary artery disease	2.76e-05	0.000223	CcSEcCtD
Atazanavir—Oedema—Ramipril—coronary artery disease	2.75e-05	0.000223	CcSEcCtD
Atazanavir—Dry mouth—Timolol—coronary artery disease	2.75e-05	0.000222	CcSEcCtD
Atazanavir—Constipation—Losartan—coronary artery disease	2.74e-05	0.000222	CcSEcCtD
Atazanavir—Pain—Losartan—coronary artery disease	2.74e-05	0.000222	CcSEcCtD
Atazanavir—Syncope—Lisinopril—coronary artery disease	2.74e-05	0.000222	CcSEcCtD
Atazanavir—Vomiting—Eplerenone—coronary artery disease	2.74e-05	0.000222	CcSEcCtD
Atazanavir—Feeling abnormal—Furosemide—coronary artery disease	2.74e-05	0.000222	CcSEcCtD
Atazanavir—Nausea—Fenofibrate—coronary artery disease	2.73e-05	0.000221	CcSEcCtD
Atazanavir—Pruritus—Niacin—coronary artery disease	2.73e-05	0.000221	CcSEcCtD
Atazanavir—Asthenia—Pravastatin—coronary artery disease	2.73e-05	0.000221	CcSEcCtD
Atazanavir—Gastrointestinal pain—Furosemide—coronary artery disease	2.72e-05	0.00022	CcSEcCtD
Atazanavir—Rash—Eplerenone—coronary artery disease	2.72e-05	0.00022	CcSEcCtD
Atazanavir—Urticaria—Perindopril—coronary artery disease	2.72e-05	0.00022	CcSEcCtD
Atazanavir—Hypersensitivity—Trandolapril—coronary artery disease	2.72e-05	0.00022	CcSEcCtD
Atazanavir—Dermatitis—Eplerenone—coronary artery disease	2.72e-05	0.00022	CcSEcCtD
Atazanavir—Diarrhoea—Valsartan—coronary artery disease	2.72e-05	0.00022	CcSEcCtD
Atazanavir—Confusional state—Timolol—coronary artery disease	2.71e-05	0.00022	CcSEcCtD
Atazanavir—Shock—Ramipril—coronary artery disease	2.71e-05	0.000219	CcSEcCtD
Atazanavir—Hypersensitivity—Enalapril—coronary artery disease	2.71e-05	0.000219	CcSEcCtD
Atazanavir—Abdominal pain—Perindopril—coronary artery disease	2.71e-05	0.000219	CcSEcCtD
Atazanavir—Body temperature increased—Perindopril—coronary artery disease	2.71e-05	0.000219	CcSEcCtD
Atazanavir—Palpitations—Lisinopril—coronary artery disease	2.7e-05	0.000219	CcSEcCtD
Atazanavir—Diarrhoea—Olmesartan—coronary artery disease	2.7e-05	0.000219	CcSEcCtD
Atazanavir—Headache—Eplerenone—coronary artery disease	2.7e-05	0.000219	CcSEcCtD
Atazanavir—Nervous system disorder—Ramipril—coronary artery disease	2.7e-05	0.000219	CcSEcCtD
Atazanavir—Oedema—Timolol—coronary artery disease	2.69e-05	0.000218	CcSEcCtD
Atazanavir—Pruritus—Pravastatin—coronary artery disease	2.69e-05	0.000218	CcSEcCtD
Atazanavir—Loss of consciousness—Lisinopril—coronary artery disease	2.69e-05	0.000218	CcSEcCtD
Atazanavir—Nausea—Clopidogrel—coronary artery disease	2.69e-05	0.000218	CcSEcCtD
Atazanavir—Skin disorder—Ramipril—coronary artery disease	2.67e-05	0.000216	CcSEcCtD
Atazanavir—Infection—Timolol—coronary artery disease	2.67e-05	0.000216	CcSEcCtD
Atazanavir—Vomiting—Simvastatin—coronary artery disease	2.67e-05	0.000216	CcSEcCtD
Atazanavir—Hypersensitivity—Telmisartan—coronary artery disease	2.67e-05	0.000216	CcSEcCtD
Atazanavir—Cough—Lisinopril—coronary artery disease	2.67e-05	0.000216	CcSEcCtD
Atazanavir—Nausea—Lovastatin—coronary artery disease	2.67e-05	0.000216	CcSEcCtD
Atazanavir—Hyperhidrosis—Ramipril—coronary artery disease	2.66e-05	0.000215	CcSEcCtD
Atazanavir—Rash—Simvastatin—coronary artery disease	2.65e-05	0.000215	CcSEcCtD
Atazanavir—Dermatitis—Simvastatin—coronary artery disease	2.65e-05	0.000214	CcSEcCtD
Atazanavir—Asthenia—Trandolapril—coronary artery disease	2.65e-05	0.000214	CcSEcCtD
Atazanavir—Shock—Timolol—coronary artery disease	2.65e-05	0.000214	CcSEcCtD
Atazanavir—Feeling abnormal—Losartan—coronary artery disease	2.65e-05	0.000214	CcSEcCtD
Atazanavir—Urticaria—Furosemide—coronary artery disease	2.64e-05	0.000214	CcSEcCtD
Atazanavir—Diarrhoea—Niacin—coronary artery disease	2.64e-05	0.000214	CcSEcCtD
Atazanavir—Nervous system disorder—Timolol—coronary artery disease	2.64e-05	0.000214	CcSEcCtD
Atazanavir—Asthenia—Enalapril—coronary artery disease	2.64e-05	0.000213	CcSEcCtD
Atazanavir—Headache—Simvastatin—coronary artery disease	2.63e-05	0.000213	CcSEcCtD
Atazanavir—Body temperature increased—Furosemide—coronary artery disease	2.63e-05	0.000213	CcSEcCtD
Atazanavir—Abdominal pain—Furosemide—coronary artery disease	2.63e-05	0.000213	CcSEcCtD
Atazanavir—Gastrointestinal pain—Losartan—coronary artery disease	2.62e-05	0.000213	CcSEcCtD
Atazanavir—Dizziness—Valsartan—coronary artery disease	2.62e-05	0.000213	CcSEcCtD
Atazanavir—Anorexia—Ramipril—coronary artery disease	2.62e-05	0.000212	CcSEcCtD
Atazanavir—Nausea—Ezetimibe—coronary artery disease	2.62e-05	0.000212	CcSEcCtD
Atazanavir—Skin disorder—Timolol—coronary artery disease	2.61e-05	0.000212	CcSEcCtD
Atazanavir—Dizziness—Olmesartan—coronary artery disease	2.61e-05	0.000211	CcSEcCtD
Atazanavir—Pruritus—Trandolapril—coronary artery disease	2.61e-05	0.000211	CcSEcCtD
Atazanavir—Arthralgia—Lisinopril—coronary artery disease	2.6e-05	0.000211	CcSEcCtD
Atazanavir—Myalgia—Lisinopril—coronary artery disease	2.6e-05	0.000211	CcSEcCtD
Atazanavir—Chest pain—Lisinopril—coronary artery disease	2.6e-05	0.000211	CcSEcCtD
Atazanavir—Hyperhidrosis—Timolol—coronary artery disease	2.6e-05	0.000211	CcSEcCtD
Atazanavir—Asthenia—Telmisartan—coronary artery disease	2.6e-05	0.000211	CcSEcCtD
Atazanavir—Pruritus—Enalapril—coronary artery disease	2.6e-05	0.000211	CcSEcCtD
Atazanavir—Diarrhoea—Pravastatin—coronary artery disease	2.6e-05	0.00021	CcSEcCtD
Atazanavir—Anxiety—Lisinopril—coronary artery disease	2.59e-05	0.00021	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.59e-05	0.000209	CcSEcCtD
Atazanavir—Discomfort—Lisinopril—coronary artery disease	2.57e-05	0.000208	CcSEcCtD
Atazanavir—Anorexia—Timolol—coronary artery disease	2.56e-05	0.000208	CcSEcCtD
Atazanavir—Pruritus—Telmisartan—coronary artery disease	2.56e-05	0.000208	CcSEcCtD
Atazanavir—Nausea—Eplerenone—coronary artery disease	2.56e-05	0.000207	CcSEcCtD
Atazanavir—Dizziness—Niacin—coronary artery disease	2.55e-05	0.000207	CcSEcCtD
Atazanavir—Urticaria—Losartan—coronary artery disease	2.55e-05	0.000206	CcSEcCtD
Atazanavir—Dry mouth—Lisinopril—coronary artery disease	2.55e-05	0.000206	CcSEcCtD
Atazanavir—Abdominal pain—Losartan—coronary artery disease	2.54e-05	0.000205	CcSEcCtD
Atazanavir—Body temperature increased—Losartan—coronary artery disease	2.54e-05	0.000205	CcSEcCtD
Atazanavir—Asthenia—Captopril—coronary artery disease	2.53e-05	0.000205	CcSEcCtD
Atazanavir—Diarrhoea—Trandolapril—coronary artery disease	2.52e-05	0.000204	CcSEcCtD
Atazanavir—Vomiting—Valsartan—coronary artery disease	2.52e-05	0.000204	CcSEcCtD
Atazanavir—Confusional state—Lisinopril—coronary artery disease	2.52e-05	0.000204	CcSEcCtD
Atazanavir—Diarrhoea—Enalapril—coronary artery disease	2.51e-05	0.000204	CcSEcCtD
Atazanavir—Dizziness—Pravastatin—coronary artery disease	2.51e-05	0.000203	CcSEcCtD
Atazanavir—Vomiting—Olmesartan—coronary artery disease	2.51e-05	0.000203	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.51e-05	0.000203	CcSEcCtD
Atazanavir—Rash—Valsartan—coronary artery disease	2.5e-05	0.000203	CcSEcCtD
Atazanavir—Dermatitis—Valsartan—coronary artery disease	2.5e-05	0.000202	CcSEcCtD
Atazanavir—Nausea—Simvastatin—coronary artery disease	2.5e-05	0.000202	CcSEcCtD
Atazanavir—Oedema—Lisinopril—coronary artery disease	2.5e-05	0.000202	CcSEcCtD
Atazanavir—Pruritus—Captopril—coronary artery disease	2.49e-05	0.000202	CcSEcCtD
Atazanavir—Rash—Olmesartan—coronary artery disease	2.49e-05	0.000202	CcSEcCtD
Atazanavir—Insomnia—Ramipril—coronary artery disease	2.49e-05	0.000202	CcSEcCtD
Atazanavir—Dermatitis—Olmesartan—coronary artery disease	2.49e-05	0.000201	CcSEcCtD
Atazanavir—Headache—Valsartan—coronary artery disease	2.49e-05	0.000201	CcSEcCtD
Atazanavir—Diarrhoea—Telmisartan—coronary artery disease	2.48e-05	0.000201	CcSEcCtD
Atazanavir—Infection—Lisinopril—coronary artery disease	2.48e-05	0.000201	CcSEcCtD
Atazanavir—Headache—Olmesartan—coronary artery disease	2.47e-05	0.0002	CcSEcCtD
Atazanavir—Shock—Lisinopril—coronary artery disease	2.46e-05	0.000199	CcSEcCtD
Atazanavir—Asthenia—Perindopril—coronary artery disease	2.46e-05	0.000199	CcSEcCtD
Atazanavir—Dyspnoea—Ramipril—coronary artery disease	2.45e-05	0.000199	CcSEcCtD
Atazanavir—Vomiting—Niacin—coronary artery disease	2.45e-05	0.000199	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Timolol—coronary artery disease	2.45e-05	0.000198	CcSEcCtD
Atazanavir—Hypersensitivity—Furosemide—coronary artery disease	2.45e-05	0.000198	CcSEcCtD
Atazanavir—Somnolence—Ramipril—coronary artery disease	2.45e-05	0.000198	CcSEcCtD
Atazanavir—Dizziness—Trandolapril—coronary artery disease	2.44e-05	0.000198	CcSEcCtD
Atazanavir—Insomnia—Timolol—coronary artery disease	2.43e-05	0.000197	CcSEcCtD
Atazanavir—Rash—Niacin—coronary artery disease	2.43e-05	0.000197	CcSEcCtD
Atazanavir—Dermatitis—Niacin—coronary artery disease	2.43e-05	0.000197	CcSEcCtD
Atazanavir—Dizziness—Enalapril—coronary artery disease	2.43e-05	0.000197	CcSEcCtD
Atazanavir—Skin disorder—Lisinopril—coronary artery disease	2.42e-05	0.000196	CcSEcCtD
Atazanavir—Dyspepsia—Ramipril—coronary artery disease	2.42e-05	0.000196	CcSEcCtD
Atazanavir—Pruritus—Perindopril—coronary artery disease	2.42e-05	0.000196	CcSEcCtD
Atazanavir—Headache—Niacin—coronary artery disease	2.42e-05	0.000196	CcSEcCtD
Atazanavir—Vomiting—Pravastatin—coronary artery disease	2.42e-05	0.000196	CcSEcCtD
Atazanavir—CYP2C9—blood—coronary artery disease	2.41e-05	0.0265	CbGeAlD
Atazanavir—Hyperhidrosis—Lisinopril—coronary artery disease	2.41e-05	0.000195	CcSEcCtD
Atazanavir—Diarrhoea—Captopril—coronary artery disease	2.41e-05	0.000195	CcSEcCtD
Atazanavir—Dyspnoea—Timolol—coronary artery disease	2.4e-05	0.000194	CcSEcCtD
Atazanavir—Dizziness—Telmisartan—coronary artery disease	2.4e-05	0.000194	CcSEcCtD
Atazanavir—Rash—Pravastatin—coronary artery disease	2.4e-05	0.000194	CcSEcCtD
Atazanavir—Dermatitis—Pravastatin—coronary artery disease	2.39e-05	0.000194	CcSEcCtD
Atazanavir—Decreased appetite—Ramipril—coronary artery disease	2.39e-05	0.000194	CcSEcCtD
Atazanavir—Somnolence—Timolol—coronary artery disease	2.39e-05	0.000194	CcSEcCtD
Atazanavir—Asthenia—Furosemide—coronary artery disease	2.39e-05	0.000193	CcSEcCtD
Atazanavir—Headache—Pravastatin—coronary artery disease	2.38e-05	0.000193	CcSEcCtD
Atazanavir—Anorexia—Lisinopril—coronary artery disease	2.38e-05	0.000193	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Ramipril—coronary artery disease	2.38e-05	0.000192	CcSEcCtD
Atazanavir—Fatigue—Ramipril—coronary artery disease	2.37e-05	0.000192	CcSEcCtD
Atazanavir—Dyspepsia—Timolol—coronary artery disease	2.37e-05	0.000192	CcSEcCtD
Atazanavir—Hypersensitivity—Losartan—coronary artery disease	2.36e-05	0.000191	CcSEcCtD
Atazanavir—Nausea—Valsartan—coronary artery disease	2.36e-05	0.000191	CcSEcCtD
Atazanavir—Pruritus—Furosemide—coronary artery disease	2.35e-05	0.000191	CcSEcCtD
Atazanavir—Constipation—Ramipril—coronary artery disease	2.35e-05	0.000191	CcSEcCtD
Atazanavir—Nausea—Olmesartan—coronary artery disease	2.35e-05	0.00019	CcSEcCtD
Atazanavir—Vomiting—Trandolapril—coronary artery disease	2.35e-05	0.00019	CcSEcCtD
Atazanavir—Diarrhoea—Perindopril—coronary artery disease	2.34e-05	0.00019	CcSEcCtD
Atazanavir—Decreased appetite—Timolol—coronary artery disease	2.34e-05	0.000189	CcSEcCtD
Atazanavir—Vomiting—Enalapril—coronary artery disease	2.34e-05	0.000189	CcSEcCtD
Atazanavir—Dizziness—Captopril—coronary artery disease	2.33e-05	0.000189	CcSEcCtD
Atazanavir—Rash—Trandolapril—coronary artery disease	2.33e-05	0.000188	CcSEcCtD
Atazanavir—Dermatitis—Trandolapril—coronary artery disease	2.32e-05	0.000188	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Timolol—coronary artery disease	2.32e-05	0.000188	CcSEcCtD
Atazanavir—Fatigue—Timolol—coronary artery disease	2.32e-05	0.000188	CcSEcCtD
Atazanavir—Rash—Enalapril—coronary artery disease	2.32e-05	0.000188	CcSEcCtD
Atazanavir—Dermatitis—Enalapril—coronary artery disease	2.31e-05	0.000187	CcSEcCtD
Atazanavir—Headache—Trandolapril—coronary artery disease	2.31e-05	0.000187	CcSEcCtD
Atazanavir—Vomiting—Telmisartan—coronary artery disease	2.3e-05	0.000187	CcSEcCtD
Atazanavir—Asthenia—Losartan—coronary artery disease	2.3e-05	0.000186	CcSEcCtD
Atazanavir—Headache—Enalapril—coronary artery disease	2.3e-05	0.000186	CcSEcCtD
Atazanavir—Pain—Timolol—coronary artery disease	2.3e-05	0.000186	CcSEcCtD
Atazanavir—Nausea—Niacin—coronary artery disease	2.29e-05	0.000186	CcSEcCtD
Atazanavir—Rash—Telmisartan—coronary artery disease	2.29e-05	0.000185	CcSEcCtD
Atazanavir—Dermatitis—Telmisartan—coronary artery disease	2.28e-05	0.000185	CcSEcCtD
Atazanavir—Diarrhoea—Furosemide—coronary artery disease	2.28e-05	0.000184	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.27e-05	0.000184	CcSEcCtD
Atazanavir—Pruritus—Losartan—coronary artery disease	2.27e-05	0.000184	CcSEcCtD
Atazanavir—Headache—Telmisartan—coronary artery disease	2.27e-05	0.000184	CcSEcCtD
Atazanavir—Feeling abnormal—Ramipril—coronary artery disease	2.27e-05	0.000184	CcSEcCtD
Atazanavir—Dizziness—Perindopril—coronary artery disease	2.26e-05	0.000183	CcSEcCtD
Atazanavir—Insomnia—Lisinopril—coronary artery disease	2.26e-05	0.000183	CcSEcCtD
Atazanavir—Nausea—Pravastatin—coronary artery disease	2.26e-05	0.000183	CcSEcCtD
Atazanavir—Gastrointestinal pain—Ramipril—coronary artery disease	2.25e-05	0.000182	CcSEcCtD
Atazanavir—Vomiting—Captopril—coronary artery disease	2.24e-05	0.000181	CcSEcCtD
Atazanavir—Dyspnoea—Lisinopril—coronary artery disease	2.23e-05	0.00018	CcSEcCtD
Atazanavir—Rash—Captopril—coronary artery disease	2.22e-05	0.00018	CcSEcCtD
Atazanavir—Dermatitis—Captopril—coronary artery disease	2.22e-05	0.00018	CcSEcCtD
Atazanavir—Somnolence—Lisinopril—coronary artery disease	2.22e-05	0.00018	CcSEcCtD
Atazanavir—Feeling abnormal—Timolol—coronary artery disease	2.22e-05	0.00018	CcSEcCtD
Atazanavir—Headache—Captopril—coronary artery disease	2.21e-05	0.000179	CcSEcCtD
Atazanavir—Gastrointestinal pain—Timolol—coronary artery disease	2.2e-05	0.000178	CcSEcCtD
Atazanavir—Dizziness—Furosemide—coronary artery disease	2.2e-05	0.000178	CcSEcCtD
Atazanavir—Dyspepsia—Lisinopril—coronary artery disease	2.2e-05	0.000178	CcSEcCtD
Atazanavir—Diarrhoea—Losartan—coronary artery disease	2.2e-05	0.000178	CcSEcCtD
Atazanavir—Nausea—Trandolapril—coronary artery disease	2.19e-05	0.000177	CcSEcCtD
Atazanavir—Urticaria—Ramipril—coronary artery disease	2.19e-05	0.000177	CcSEcCtD
Atazanavir—Nausea—Enalapril—coronary artery disease	2.18e-05	0.000177	CcSEcCtD
Atazanavir—Vomiting—Perindopril—coronary artery disease	2.18e-05	0.000176	CcSEcCtD
Atazanavir—Abdominal pain—Ramipril—coronary artery disease	2.18e-05	0.000176	CcSEcCtD
Atazanavir—Body temperature increased—Ramipril—coronary artery disease	2.18e-05	0.000176	CcSEcCtD
Atazanavir—Decreased appetite—Lisinopril—coronary artery disease	2.17e-05	0.000176	CcSEcCtD
Atazanavir—Rash—Perindopril—coronary artery disease	2.16e-05	0.000175	CcSEcCtD
Atazanavir—Dermatitis—Perindopril—coronary artery disease	2.16e-05	0.000175	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.15e-05	0.000174	CcSEcCtD
Atazanavir—Nausea—Telmisartan—coronary artery disease	2.15e-05	0.000174	CcSEcCtD
Atazanavir—Fatigue—Lisinopril—coronary artery disease	2.15e-05	0.000174	CcSEcCtD
Atazanavir—Headache—Perindopril—coronary artery disease	2.14e-05	0.000174	CcSEcCtD
Atazanavir—Urticaria—Timolol—coronary artery disease	2.14e-05	0.000173	CcSEcCtD
Atazanavir—Pain—Lisinopril—coronary artery disease	2.13e-05	0.000173	CcSEcCtD
Atazanavir—Constipation—Lisinopril—coronary artery disease	2.13e-05	0.000173	CcSEcCtD
Atazanavir—Body temperature increased—Timolol—coronary artery disease	2.13e-05	0.000172	CcSEcCtD
Atazanavir—Abdominal pain—Timolol—coronary artery disease	2.13e-05	0.000172	CcSEcCtD
Atazanavir—Dizziness—Losartan—coronary artery disease	2.12e-05	0.000172	CcSEcCtD
Atazanavir—Vomiting—Furosemide—coronary artery disease	2.12e-05	0.000171	CcSEcCtD
Atazanavir—Rash—Furosemide—coronary artery disease	2.1e-05	0.00017	CcSEcCtD
Atazanavir—Dermatitis—Furosemide—coronary artery disease	2.1e-05	0.00017	CcSEcCtD
Atazanavir—Nausea—Captopril—coronary artery disease	2.09e-05	0.00017	CcSEcCtD
Atazanavir—Headache—Furosemide—coronary artery disease	2.08e-05	0.000169	CcSEcCtD
Atazanavir—Feeling abnormal—Lisinopril—coronary artery disease	2.06e-05	0.000167	CcSEcCtD
Atazanavir—Gastrointestinal pain—Lisinopril—coronary artery disease	2.04e-05	0.000165	CcSEcCtD
Atazanavir—Vomiting—Losartan—coronary artery disease	2.04e-05	0.000165	CcSEcCtD
Atazanavir—Nausea—Perindopril—coronary artery disease	2.03e-05	0.000165	CcSEcCtD
Atazanavir—Hypersensitivity—Ramipril—coronary artery disease	2.03e-05	0.000164	CcSEcCtD
Atazanavir—Rash—Losartan—coronary artery disease	2.02e-05	0.000164	CcSEcCtD
Atazanavir—Dermatitis—Losartan—coronary artery disease	2.02e-05	0.000164	CcSEcCtD
Atazanavir—Headache—Losartan—coronary artery disease	2.01e-05	0.000163	CcSEcCtD
Atazanavir—Urticaria—Lisinopril—coronary artery disease	1.98e-05	0.000161	CcSEcCtD
Atazanavir—Hypersensitivity—Timolol—coronary artery disease	1.98e-05	0.000161	CcSEcCtD
Atazanavir—Nausea—Furosemide—coronary artery disease	1.98e-05	0.00016	CcSEcCtD
Atazanavir—Asthenia—Ramipril—coronary artery disease	1.97e-05	0.00016	CcSEcCtD
Atazanavir—Body temperature increased—Lisinopril—coronary artery disease	1.97e-05	0.00016	CcSEcCtD
Atazanavir—Abdominal pain—Lisinopril—coronary artery disease	1.97e-05	0.00016	CcSEcCtD
Atazanavir—Pruritus—Ramipril—coronary artery disease	1.95e-05	0.000158	CcSEcCtD
Atazanavir—Asthenia—Timolol—coronary artery disease	1.93e-05	0.000156	CcSEcCtD
Atazanavir—Nausea—Losartan—coronary artery disease	1.91e-05	0.000154	CcSEcCtD
Atazanavir—Pruritus—Timolol—coronary artery disease	1.9e-05	0.000154	CcSEcCtD
Atazanavir—Diarrhoea—Ramipril—coronary artery disease	1.88e-05	0.000152	CcSEcCtD
Atazanavir—Diarrhoea—Timolol—coronary artery disease	1.84e-05	0.000149	CcSEcCtD
Atazanavir—CYP3A4—blood—coronary artery disease	1.84e-05	0.0202	CbGeAlD
Atazanavir—Hypersensitivity—Lisinopril—coronary artery disease	1.84e-05	0.000149	CcSEcCtD
Atazanavir—Dizziness—Ramipril—coronary artery disease	1.82e-05	0.000147	CcSEcCtD
Atazanavir—Asthenia—Lisinopril—coronary artery disease	1.79e-05	0.000145	CcSEcCtD
Atazanavir—Dizziness—Timolol—coronary artery disease	1.78e-05	0.000144	CcSEcCtD
Atazanavir—Pruritus—Lisinopril—coronary artery disease	1.77e-05	0.000143	CcSEcCtD
Atazanavir—Vomiting—Ramipril—coronary artery disease	1.75e-05	0.000142	CcSEcCtD
Atazanavir—ABCB1—heart—coronary artery disease	1.75e-05	0.0192	CbGeAlD
Atazanavir—Rash—Ramipril—coronary artery disease	1.74e-05	0.000141	CcSEcCtD
Atazanavir—Dermatitis—Ramipril—coronary artery disease	1.73e-05	0.00014	CcSEcCtD
Atazanavir—Headache—Ramipril—coronary artery disease	1.72e-05	0.00014	CcSEcCtD
Atazanavir—Vomiting—Timolol—coronary artery disease	1.71e-05	0.000139	CcSEcCtD
Atazanavir—Diarrhoea—Lisinopril—coronary artery disease	1.71e-05	0.000138	CcSEcCtD
Atazanavir—Rash—Timolol—coronary artery disease	1.7e-05	0.000137	CcSEcCtD
Atazanavir—Dermatitis—Timolol—coronary artery disease	1.69e-05	0.000137	CcSEcCtD
Atazanavir—Headache—Timolol—coronary artery disease	1.69e-05	0.000136	CcSEcCtD
Atazanavir—Dizziness—Lisinopril—coronary artery disease	1.65e-05	0.000134	CcSEcCtD
Atazanavir—ABCB1—cardiovascular system—coronary artery disease	1.65e-05	0.0181	CbGeAlD
Atazanavir—Nausea—Ramipril—coronary artery disease	1.63e-05	0.000132	CcSEcCtD
Atazanavir—Nausea—Timolol—coronary artery disease	1.6e-05	0.000129	CcSEcCtD
Atazanavir—Vomiting—Lisinopril—coronary artery disease	1.59e-05	0.000129	CcSEcCtD
Atazanavir—Rash—Lisinopril—coronary artery disease	1.57e-05	0.000127	CcSEcCtD
Atazanavir—Dermatitis—Lisinopril—coronary artery disease	1.57e-05	0.000127	CcSEcCtD
Atazanavir—Headache—Lisinopril—coronary artery disease	1.56e-05	0.000127	CcSEcCtD
Atazanavir—Nausea—Lisinopril—coronary artery disease	1.48e-05	0.00012	CcSEcCtD
Atazanavir—ABCB1—blood—coronary artery disease	1.3e-05	0.0143	CbGeAlD
Atazanavir—CYP3A4—Metabolism—UGCG—coronary artery disease	4.79e-06	0.000223	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MDH2—coronary artery disease	4.79e-06	0.000223	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLCD1—coronary artery disease	4.79e-06	0.000223	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HADHA—coronary artery disease	4.77e-06	0.000222	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APOE—coronary artery disease	4.75e-06	0.000222	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—LPL—coronary artery disease	4.75e-06	0.000221	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	4.74e-06	0.000221	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTA1—coronary artery disease	4.71e-06	0.00022	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	4.71e-06	0.00022	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APOA1—coronary artery disease	4.7e-06	0.000219	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LPA—coronary artery disease	4.66e-06	0.000217	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GPX1—coronary artery disease	4.63e-06	0.000216	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	4.63e-06	0.000216	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PGM1—coronary artery disease	4.62e-06	0.000215	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOA2—coronary artery disease	4.57e-06	0.000213	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GPX2—coronary artery disease	4.57e-06	0.000213	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	4.57e-06	0.000213	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PLCB3—coronary artery disease	4.52e-06	0.00021	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CD36—coronary artery disease	4.51e-06	0.00021	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HK1—coronary artery disease	4.51e-06	0.00021	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCG5—coronary artery disease	4.51e-06	0.00021	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GPX4—coronary artery disease	4.51e-06	0.00021	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SULT1A1—coronary artery disease	4.51e-06	0.00021	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	4.5e-06	0.00021	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOA5—coronary artery disease	4.47e-06	0.000208	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6ST—coronary artery disease	4.47e-06	0.000208	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CKB—coronary artery disease	4.46e-06	0.000208	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PPP2CA—coronary artery disease	4.46e-06	0.000208	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PYGB—coronary artery disease	4.46e-06	0.000208	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HADHA—coronary artery disease	4.46e-06	0.000208	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOS2—coronary artery disease	4.43e-06	0.000206	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ALB—coronary artery disease	4.41e-06	0.000206	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTA1—coronary artery disease	4.4e-06	0.000205	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—P4HB—coronary artery disease	4.38e-06	0.000204	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LPA—coronary artery disease	4.36e-06	0.000203	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PLA2G1B—coronary artery disease	4.3e-06	0.0002	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	4.29e-06	0.0002	CbGpPWpGaD
Atazanavir—ABCC1—Disease—KIT—coronary artery disease	4.29e-06	0.0002	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—MTHFR—coronary artery disease	4.28e-06	0.000199	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—NOS3—coronary artery disease	4.22e-06	0.000197	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PLCB3—coronary artery disease	4.22e-06	0.000197	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTM2—coronary artery disease	4.19e-06	0.000195	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—DLAT—coronary artery disease	4.19e-06	0.000195	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLIN1—coronary artery disease	4.19e-06	0.000195	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—COX5B—coronary artery disease	4.19e-06	0.000195	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PFKFB3—coronary artery disease	4.19e-06	0.000195	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOA5—coronary artery disease	4.18e-06	0.000195	CbGpPWpGaD
Atazanavir—ABCC1—Disease—GSK3B—coronary artery disease	4.12e-06	0.000192	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—P4HB—coronary artery disease	4.09e-06	0.000191	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CREB1—coronary artery disease	4.08e-06	0.00019	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AGT—coronary artery disease	4.06e-06	0.000189	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	4.06e-06	0.000189	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—VCAN—coronary artery disease	4.06e-06	0.000189	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALDOA—coronary artery disease	4.02e-06	0.000188	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	4.02e-06	0.000187	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	4e-06	0.000186	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6R—coronary artery disease	3.98e-06	0.000186	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—APOE—coronary artery disease	3.98e-06	0.000186	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	3.97e-06	0.000185	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SULT1E1—coronary artery disease	3.97e-06	0.000185	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—APOA1—coronary artery disease	3.94e-06	0.000183	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	3.93e-06	0.000183	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—DCN—coronary artery disease	3.91e-06	0.000182	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTGS2—coronary artery disease	3.86e-06	0.00018	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALDH2—coronary artery disease	3.8e-06	0.000177	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HK2—coronary artery disease	3.79e-06	0.000177	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKR1B1—coronary artery disease	3.79e-06	0.000177	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—VCAN—coronary artery disease	3.79e-06	0.000177	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.77e-06	0.000176	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALDOA—coronary artery disease	3.76e-06	0.000175	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SERPINE1—coronary artery disease	3.73e-06	0.000174	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LIPC—coronary artery disease	3.7e-06	0.000173	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HBA1—coronary artery disease	3.7e-06	0.000173	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2C19—coronary artery disease	3.7e-06	0.000173	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3C2A—coronary artery disease	3.7e-06	0.000173	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOC3—coronary artery disease	3.68e-06	0.000172	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LDLR—coronary artery disease	3.66e-06	0.00017	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—DCN—coronary artery disease	3.65e-06	0.00017	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC27A1—coronary artery disease	3.63e-06	0.000169	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC9A1—coronary artery disease	3.61e-06	0.000168	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTT1—coronary artery disease	3.61e-06	0.000168	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FGF2—coronary artery disease	3.61e-06	0.000168	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CETP—coronary artery disease	3.57e-06	0.000166	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GCLC—coronary artery disease	3.57e-06	0.000166	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CPT1B—coronary artery disease	3.56e-06	0.000166	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LCAT—coronary artery disease	3.56e-06	0.000166	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOS3—coronary artery disease	3.56e-06	0.000166	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALDH2—coronary artery disease	3.55e-06	0.000165	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SDC1—coronary artery disease	3.53e-06	0.000165	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	3.51e-06	0.000163	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOA4—coronary artery disease	3.5e-06	0.000163	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PPARG—coronary artery disease	3.47e-06	0.000162	CbGpPWpGaD
Atazanavir—ABCC1—Disease—JAK2—coronary artery disease	3.46e-06	0.000161	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	3.46e-06	0.000161	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LIPC—coronary artery disease	3.46e-06	0.000161	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HBA1—coronary artery disease	3.46e-06	0.000161	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2C19—coronary artery disease	3.46e-06	0.000161	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	3.46e-06	0.000161	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOC3—coronary artery disease	3.44e-06	0.00016	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—POMC—coronary artery disease	3.42e-06	0.000159	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LDLR—coronary artery disease	3.42e-06	0.000159	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.41e-06	0.000159	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.38e-06	0.000157	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GCLM—coronary artery disease	3.38e-06	0.000157	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTT1—coronary artery disease	3.38e-06	0.000157	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC9A1—coronary artery disease	3.38e-06	0.000157	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CETP—coronary artery disease	3.34e-06	0.000156	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GCLC—coronary artery disease	3.34e-06	0.000156	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PSMA6—coronary artery disease	3.34e-06	0.000156	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PSMB5—coronary artery disease	3.34e-06	0.000156	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SDC1—coronary artery disease	3.3e-06	0.000154	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.27e-06	0.000152	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.27e-06	0.000152	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CTGF—coronary artery disease	3.26e-06	0.000152	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTGS2—coronary artery disease	3.26e-06	0.000152	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HMGCR—coronary artery disease	3.23e-06	0.000151	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GOT2—coronary artery disease	3.23e-06	0.000151	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.22e-06	0.00015	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.18e-06	0.000148	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HADH—coronary artery disease	3.18e-06	0.000148	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	3.17e-06	0.000148	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALB—coronary artery disease	3.12e-06	0.000145	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PSMA6—coronary artery disease	3.12e-06	0.000145	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PSMB5—coronary artery disease	3.12e-06	0.000145	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.11e-06	0.000145	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CTGF—coronary artery disease	3.05e-06	0.000142	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HMGCR—coronary artery disease	3.02e-06	0.000141	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GOT2—coronary artery disease	3.02e-06	0.000141	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GPX2—coronary artery disease	3.01e-06	0.00014	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOA2—coronary artery disease	3.01e-06	0.00014	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.01e-06	0.00014	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—NOS3—coronary artery disease	2.98e-06	0.000139	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.97e-06	0.000139	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GPX4—coronary artery disease	2.97e-06	0.000139	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.97e-06	0.000139	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HK1—coronary artery disease	2.97e-06	0.000139	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PLCB1—coronary artery disease	2.97e-06	0.000138	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HADHA—coronary artery disease	2.94e-06	0.000137	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.9e-06	0.000135	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ABCA1—coronary artery disease	2.88e-06	0.000134	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LPA—coronary artery disease	2.87e-06	0.000134	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GGT1—coronary artery disease	2.79e-06	0.00013	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GOT1—coronary artery disease	2.79e-06	0.00013	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.78e-06	0.00013	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PLCB1—coronary artery disease	2.78e-06	0.000129	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOA5—coronary artery disease	2.75e-06	0.000128	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTGS2—coronary artery disease	2.73e-06	0.000127	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.72e-06	0.000127	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—P4HB—coronary artery disease	2.7e-06	0.000126	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCA1—coronary artery disease	2.69e-06	0.000125	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.65e-06	0.000124	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GGT1—coronary artery disease	2.61e-06	0.000121	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GOT1—coronary artery disease	2.61e-06	0.000121	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTP1—coronary artery disease	2.51e-06	0.000117	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—VCAN—coronary artery disease	2.5e-06	0.000116	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.48e-06	0.000116	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.48e-06	0.000116	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HMOX1—coronary artery disease	2.47e-06	0.000115	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CAT—coronary artery disease	2.44e-06	0.000114	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—DCN—coronary artery disease	2.41e-06	0.000112	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CA—coronary artery disease	2.37e-06	0.000111	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOB—coronary artery disease	2.37e-06	0.00011	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TGFB1—coronary artery disease	2.36e-06	0.00011	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.34e-06	0.000109	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.34e-06	0.000109	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.32e-06	0.000108	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MAPK1—coronary artery disease	2.31e-06	0.000108	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.31e-06	0.000108	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTM1—coronary artery disease	2.3e-06	0.000107	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.28e-06	0.000106	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HBA1—coronary artery disease	2.28e-06	0.000106	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LIPC—coronary artery disease	2.28e-06	0.000106	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.28e-06	0.000106	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CAT—coronary artery disease	2.28e-06	0.000106	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOC3—coronary artery disease	2.27e-06	0.000106	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LPL—coronary artery disease	2.26e-06	0.000105	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LDLR—coronary artery disease	2.25e-06	0.000105	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.23e-06	0.000104	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.23e-06	0.000104	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOB—coronary artery disease	2.21e-06	0.000103	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GPX1—coronary artery disease	2.21e-06	0.000103	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GCLC—coronary artery disease	2.2e-06	0.000103	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CETP—coronary artery disease	2.2e-06	0.000103	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SDC1—coronary artery disease	2.18e-06	0.000101	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.15e-06	0.0001	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CD36—coronary artery disease	2.15e-06	0.0001	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.12e-06	9.88e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LPL—coronary artery disease	2.11e-06	9.84e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GPX1—coronary artery disease	2.06e-06	9.6e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.06e-06	9.58e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.06e-06	9.58e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MTHFR—coronary artery disease	2.03e-06	9.48e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CTGF—coronary artery disease	2.01e-06	9.36e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CD36—coronary artery disease	2.01e-06	9.35e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CA—coronary artery disease	2e-06	9.34e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.99e-06	9.28e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GOT2—coronary artery disease	1.99e-06	9.28e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.98e-06	9.23e-05	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AKT1—coronary artery disease	1.94e-06	9.04e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AGT—coronary artery disease	1.93e-06	9.01e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.9e-06	8.86e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOE—coronary artery disease	1.89e-06	8.83e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOA1—coronary artery disease	1.87e-06	8.73e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.83e-06	8.53e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AGT—coronary artery disease	1.81e-06	8.42e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6—coronary artery disease	1.78e-06	8.27e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.77e-06	8.27e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOE—coronary artery disease	1.77e-06	8.25e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOA1—coronary artery disease	1.75e-06	8.15e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GOT1—coronary artery disease	1.72e-06	8.01e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GGT1—coronary artery disease	1.72e-06	8.01e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CA—coronary artery disease	1.68e-06	7.82e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.68e-06	7.81e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPARG—coronary artery disease	1.65e-06	7.69e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT1—coronary artery disease	1.64e-06	7.63e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—POMC—coronary artery disease	1.63e-06	7.58e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.54e-06	7.19e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPARG—coronary artery disease	1.54e-06	7.18e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.53e-06	7.13e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.52e-06	7.09e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—POMC—coronary artery disease	1.52e-06	7.08e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CAT—coronary artery disease	1.5e-06	7e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALB—coronary artery disease	1.48e-06	6.91e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOB—coronary artery disease	1.46e-06	6.79e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NOS3—coronary artery disease	1.42e-06	6.61e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.42e-06	6.61e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LPL—coronary artery disease	1.39e-06	6.49e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALB—coronary artery disease	1.39e-06	6.46e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AKT1—coronary artery disease	1.37e-06	6.39e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GPX1—coronary artery disease	1.36e-06	6.33e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NOS3—coronary artery disease	1.33e-06	6.18e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CD36—coronary artery disease	1.32e-06	6.16e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.31e-06	6.09e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS2—coronary artery disease	1.3e-06	6.05e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.25e-06	5.84e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.21e-06	5.65e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AGT—coronary artery disease	1.19e-06	5.55e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOE—coronary artery disease	1.17e-06	5.44e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOA1—coronary artery disease	1.15e-06	5.38e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPARG—coronary artery disease	1.02e-06	4.74e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—POMC—coronary artery disease	1e-06	4.67e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALB—coronary artery disease	9.14e-07	4.26e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NOS3—coronary artery disease	8.74e-07	4.07e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS2—coronary artery disease	8e-07	3.73e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CA—coronary artery disease	7.99e-07	3.72e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CA—coronary artery disease	7.46e-07	3.48e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKT1—coronary artery disease	6.52e-07	3.04e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKT1—coronary artery disease	6.09e-07	2.84e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.92e-07	2.29e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKT1—coronary artery disease	4.02e-07	1.87e-05	CbGpPWpGaD
